Carolyn Gordon
Carolyn Gordon is EFPIA Deputy Topic Lead on the ICH Q1 revision EWG and Senior Director of CMC Regulatory Affairs at AstraZeneca.
JournalICH Q1 guideline revisions to promote innovation and enable global patient access to high-quality medicines
This article looks at the new ICH Q1 stability guidance and its various approaches to help promote innovation.